Abstract

Non-esterified fatty acids (NEFAs) promote de novo lipogenesis, which caused abnormal hepatic lipid accumulation, by the NFκB–Orai1 pathway. Oxidative stress and endoplasmic reticulum (ER) stress have been recognized as key mechanisms in non-alcoholic fatty liver disease (NAFLD) pathogenesis. Whether Orai1 facilitates ER stress by oxidative stress remains unknown. The rat model of NAFLD was constructed by feeding high-fat diet (HFD). BRL-3A cells were treated with NEFAs, Orai1inhibtor BTP2, NFκB inhibitor wogonin, or small interfering Orai (siOrai) 1, respectively. The content of intracellular reduced glutathione (GSH) and malondialdehyde (MDA), indicating oxidative stress, was measured by a spectrophotometer. ER stress major proteins PERK, IRE1, ATF6, CHOP, and GRP78 were quantified using Western blot and qRT-PCR analyses. For the intracellular location of reactive oxygen species (ROS) and Orai1 were measured by Western blot and immunofluorescence, and cytosolic Ca2+ was measured by flow cytometry. As we expected, the liver of rats with NAFLD showed lipid droplets in HE and Oil Red O. The decreased GSH and increased MDA were found in rats fed with HFD. ER stress major proteins PERK, IRE1, ATF6, GRP78, and CHOP were significantly increased in the HFD group. In BRL-3A cells, GSH content dramatically decreased from 1 h, MDA content dramatically increased from 3 h, and expression levels of ER stress significantly increased from 3 h by NEFA treatment. Furthermore, cytosolic Ca2+ increased from 0.5 h by NEFAs treated in BRL-3A cells. It indicated that NEFAs increased cytosolic Ca2+ to induce oxidative stress, thus ER stress. The content of oxidative stress and ER stress proteins showed the same trends by NEFAs treated in BRL-3A cells. These effects were reversed by the Orai1 inhibitor BTP2 and the NFκB inhibitor wogonin. Moreover, siOrai1 abrogated NEFAs’ influence in BRL-3A cells. Last, ROS was found by NEFAs treated in BRL-3A cells, and NEFA treatment enhanced the nuclear localization of NF-κB p65 and ORAI1. It was considered that high NEFAs increased cytosolic Ca2+ and enhanced NFκB-dependent SOCE and its moiety protein Orai1 to decrease GSH and thus induced oxidative stress at earlier stages and furthermore tempted ER stress in the pathologic progress of NAFLD.

Highlights

  • Non-alcoholic fatty liver disease (NAFLD) is a common chronic health problem with increasing prevalence worldwide and progresses to non-alcoholic steatohepatitis, cirrhosis, obesity, and type II diabetes in both adults and children

  • Plasma Non-esterified fatty acids (NEFAs) was measured by Non-esterified Free fatty acids assay kit, and the results showed significantly higher (p = 0.0073) concentration in the high-fat diet (HFD) group (1.383 ± 0.042) than the control group (1.003 ± 0.061)

  • GSH and MDA were measured by a spectrophotometer; protein expression of GRP78, PERK, IRE, ATF6, CHOP, Orai1, and NFκB p65 were measured by Western blot

Read more

Summary

Introduction

Non-alcoholic fatty liver disease (NAFLD) is a common chronic health problem with increasing prevalence worldwide and progresses to non-alcoholic steatohepatitis, cirrhosis, obesity, and type II diabetes in both adults and children. The pathological characterizations of NAFLD are aberrant lipid accumulation, inflammation, and fibrotic scarring in liver. Basic and clinical evidence indicated that NAFLD has a strong relationship to insulin resistance. The first hit is insulin resistance, which leads to hepatic fat accumulation; the second hit is regulation of free fatty acids by the adipokines (leptin, adiponectin, resistin) to induce mitochondrial dysfunction and oxidative stress (Zeng et al, 2014). High-plasma non-esterified fatty acids (NEFAs) level is a pathological characteristic of NAFLD, obesity, and metabolic syndrome (Engin, 2017). NEFAs are any fatty acids (above C10), rather than being esterified with glycerol to form a glyceride or other lipid. Plasma NEFAs mainly include palmitic acid, palmitoleic acid, stearate, oleic acid, and linoleic acid (Diraison et al, 2003; Donnelly et al, 2005; Hetherington et al, 2016)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call